Reuters logo
BRIEF-Hunan Er-Kang Pharmaceutical's Q3, 9-month net profits down
October 27, 2017 / 9:58 AM / 25 days ago

BRIEF-Hunan Er-Kang Pharmaceutical's Q3, 9-month net profits down

Oct 27 (Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd

* Says its 9-month net profit down 23.2 percent y/y at 554.8 million yuan ($83.47 million)

* Says its Q3 net profit down 32.4 percent y/y

Source text in Chinese: bit.ly/2xrAN72

Further company coverage: ($1 = 6.6470 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below